Author

Mark E. Fitzgerald

C4 Therapeutics (United States)ORCID 0009-0001-9449-7892Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Research Focus:protein folding & dynamics· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Aaron H. NileiD· 1 shared Aleksandr GauniD· 1 shared David StokoeiD· 1 shared Fiona Elizabeth McAllisteriD· 1 shared Katrina L. JacksoniD· 1 shared Kirill BersukeriD· 1 shared Niclas OlssoniD· 1 shared Sammy VillaiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

Aaron H. NileORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cell BiologybioRxivPreprintMay 27, 2026

Site-specific combinatorial ubiquitination drives the targeted degradation of plasma membrane proteins

Niclas Olsson, Aleksandr Gaun, Sammy Villa…·Kirill Bersuker

This study identifies ubiquitination sites on RTKs that mediate their degradation via CRLs and shows that multiple ubiquitination sites are required for effective degradation.

DOI 10.64898/2026.05.23.727405

humanproteomics

𝕏 PostBluesky